Home › Products › Nephrology › Citraphos Tablet
Citraphos Tablet
Salt Composition: FERRIC CITRATE
- Manufacturer: LA RENON HEALTHCARE PVT LTD
- Pack Size: 10 TABLET(s) IN A STRIP
- Dosage Form: TABLET
- Strength: 210MG
- Prescription Required
- Storage: Store at room temperature, between 20°C to 25°C (68°F to 77°F). Keep away from moisture, heat, and light. It should not be frozen. Keep away from children and pets.
₹204.00₹223.12
Inclusive of all taxes
Product Introduction
Citraphos tablet contains ferric citrate as its active component. It is a medication used to treat iron deficiency anemia and hyperphosphatemia (elevated phosphate levels in the body). It functions as a phosphate binder prescribed to manage hyperphosphatemia in patients with chronic kidney disease undergoing dialysis. It also serves as an iron supplement that provides elemental iron necessary for red blood cell production. Iron is essential for synthesising haemoglobin, a protein in red blood cells that transports oxygen throughout the body, and is an essential nutrient for energy production and metabolism. This medication is commonly prescribed when oral iron supplements alone prove insufficient or poorly tolerated. Inform your healthcare provider about any pre-existing medical conditions, including gastrointestinal disorders, liver disease, kidney disease, or other health conditions. These may necessitate special precautions or adjustments in the use of Citraphos tablets. Certain gastrointestinal disorders, such as ulcerative colitis, Crohn's disease, or other conditions affecting iron absorption, may require special caution when using Citraphos tablets. The underlying condition should be managed and optimised before considering iron supplementation. If you have a known allergy or hypersensitivity to Citraphos tablet or other ingredients in the medication, you should avoid its use. This medication should not be used in individuals with iron overload conditions such as haemochromatosis, haemosiderosis, or other conditions that cause excessive iron accumulation in the body.
Uses
Citraphos tablet is used in the treatment of the following: Iron deficiency anemia Hyperphosphatemia
How it works
The therapeutic effect of Citraphos tablet is the replenishment of iron stores in the body, improving symptoms of iron deficiency anemia, increased energy levels, enhanced cognitive function, potential improvements in exercise performance, and specific benefits for individuals with chronic kidney disease. It helps address the underlying iron deficiency, promoting the production of red blood cells, oxygen transport, and overall well-being.
How to Use
Take the medication exactly as prescribed by your healthcare provider. The dosage and frequency will be determined based on your specific needs, the severity of your condition, and other factors. Citraphos tablet is typically taken orally with water. Follow the instructions on whether to take it with or without food.
Side Effects
Citraphos tablet cause some side effects like all medications, although not everyone will experience them. Serious: Allergic reactions Skin rashes Common: Dark stools Diarrhea, nausea, vomiting Constipation High potassium levels in the blood Abdominal pain Cough
Expert Tips
Advice regarding Citraphos tablet is to always consult with a healthcare professional before starting or making any changes to your medication regimen. They can assess your specific medical history, evaluate potential risks and benefits, provide personalized guidance, and monitor your progress throughout treatment. Additionally, closely follow the instructions and recommendations given by your healthcare provider, report any unusual or concerning symptoms promptly, and communicate openly about any concerns or questions you may have. Pregnant and breastfeeding individuals should consult with healthcare professionals before using this medication. Your healthcare professional is the best resource for ensuring safe and effective medication use.
References
- Akebia Therapeutics, Inc., US Food & Drug Administration, [Revised on Mar 2021] [Accessed on 13th July 2023], https://fda.report/DailyMed/AADD18E0-3752-11E4-8510-0800200C9A66.pdf
- Propak Health Ltd, European Medicine Agency, [Revised on Sept, 2015] [Accessed on 13th July 2021], https://www.ema.europa.eu/en/documents/product-information/fexeric-epar-product-information_en.pdf
- J. Goddard, A.N. Turner, Kidney and Urinary Tract Disease, Davidsonâs Principles and Practice of Medicine, 22nd Edition, 2014, 461-523.
Safety Advice
Pregnancy: Consult your doctor Limited data regarding Citraphos tablet safety during pregnancy is available, so a healthcare professional should discuss and carefully evaluate its use during pregnancy.
Lungs: Consult your doctor If you have any pre-existing lung conditions, informing your healthcare provider about them before starting any new medication is important.
Breastfeeding: Consult your doctor The safety of Citraphos tablet during breastfeeding is not well established, and it is recommended to exercise caution and consult with a healthcare professional before using this medication while breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.